meostatic environment for the brain in the physio logical state.
Under various pathological conditions such as trauma, incomplete ischemia, reperfusion after complete ischemia, tumor, and allergic or inflam matory diseases, an opening of the BBB can occur. This leads to vasogenic brain edema (Klatzo, 1967 (Klatzo, , 1987 and development of secondary brain damage (Baethmann et aI. , 1982) . The essential events in the development of vasogenic edema are (a) in creased vascular permeability, (b) enhancement of driving forces, inducing a bulk flow into the inter stitial space, and (c) retention of fluid.
Several mechanisms may increase the perme ability of the cerebral vessel wall: (a) opening of tight junctions, (b) enhanced vesicular transport, (c) creation of trans cellular channels, and (d) damage of endothelial plasma membranes. Tr ans cellular channels have been very rarely found in ce rebral endothelium and may be due to fixation pro cedures (Nagy, 1986) . Marked alterations of the venous endothelium with eventual penetration of polymorphonuclear granulocytes through the endo thelial membranes have recently been found after exposure to arachidonic acid (U nterberg et aI. , 1987a) . Opening of tight junctions due to distention by an increase of venular pressure (Auer et aI. , 1980; Haggendal and Johansson, 1972; Mayhan and Heistad, 1986; Mayhan et aI. , 1986b; Rapoport, 1976b) and stimulation of vesicular transport (Hansson and Johansson, 1980; Nag et aI. , 1979; Westergaard, 1977) were discussed as alternative mechanisms of BBB opening during hypertension. The involvement of vesicular transport and junc tional opening in the increase in BBB permeability is still under discussion but the significance of pino cytosis for transcellular transport is not generally accepted as reviewed elsewhere (Bundgaard, 1980; Crone, 1986b; Mchedlishvili et aI. , 1986; Rapoport and Robinson, 1986) .
The role of chemical mediators in opening of the BBB has been neglected for a long time, although the significance of autacoids in the development of edema in the peripheral circulation is widely ac cepted. Therefore, some recent articles on the in fluence of autacoids on BBB permeability and de velopment of brain edema will be shortly reviewed. Five characteristics will be discussed for each me diator candidate: (a) increase in cerebral vascular permeability, (b) vasomotor responses that can change driving forces for transmural bulk flow, (c) edema formation, (d) change of mediator concen tration in tissue or interstitial fluid during patholog ical events, and (e) therapeutical results.
BRADYKININ
The influence of bradykinin on BBB function was determined by intravital fluorescence micros copy in the cat (Unterberg et aI. , 1983b (Unterberg et aI. , , 1984 Wahl et aI. , 1983a Wahl et aI. , , 1985a . Under control conditions, all BBB markers tested remained in the intravascular space. Cortical superfusion with bradykinin in duced a leakage from pial vessels of N a + -fluores cein with a molecular weight (MW) of 376 at 4 x 10-7 to 4 X 10-6 M. This started as single fluores cent spots around small veins. Extravasation of flu orescein isothiocyanate (FITC) labeled albumin (MW, 67,000) or FITC-dextran (MW, 19,400-62,000) could not be elicited in the cat even at bra dykinin concentrations up to 4 X 10-3 M (Unter berg et aI. , 1984) . From the hydrodynamic radius of the tracers it was concluded that bradykinin causes a selective increase in BBB permeability by opening of functional pores with a diameter of at least 11 to 15 A. The upper limit of the pore size was not determined exactly, but FITC-dextran (MW, 19, 400) with a Stokes' radius of 30 A could definitely not penetrate the BBB during administra tion of bradykinin (Unterberg et aI. , 1984) . Because vesicular transport was not increased in the cat (F. Hammersen and A. Unterberg, unpublished re sults), widening of tight junctions due to brady kinin-induced contraction of endothelial cells was suggested as a mechanism (U nterberg et aI. , 1984) . This is compatible with the finding of the same au thors that isoproterenol inhibited the bradykinin-in duced leakage that can be explained by a relaxation of endothelial cells according to Svensjo et al. (1979) .
Further support to the hypothesis that bradykinin opens tight junctions is given by recent findings. Colden-Stanfield et ai. (1987) found a bradykinin induced increase in cytosolic Ca 2 + of bovine aortic J Cereb Blood Flow Me/ab, Vol. 8, No.5, /988 endothelial cells. Furthermore, bradykinin or aug mentation of the cytosolic Ca 2 + concentration in creased ion permeability of frog cerebral venules (Olesen and Crone, 1986; Olesen, 1987a) , which might be due to a shortening of contractile proteins found in cerebral endothelial cells (Owman et aI. , 1977) . However, increased pinocytosis has also been found in the rat after intracarotid infusion of bradykinin (Raymond et aI. , 1986) .
Intracarotid infusion of bradykinin leading to concentrations of 10-6 to 10-5 M in sagittal sinus blood-induced leakage of Na + -fl uorescein but not of FITC-dextran (MW, 62,000) from cat pial vessels (Unterberg et aI. , 1984) . Discrepant results were obtained in the rat. After intravenous injection of � 10-6-10-5 M bradykinin/kg BW no extravasation of tracers into the brain could be detected (Gab biani et aI. , 1970; Saria et aI. , 1983) . However, both these groups also did not detect an opening of the BBB after exposure to histamine or serotonin. Raymond et ai. (1986) found leakage of horseradish peroxidase (MW, 40,000) after 3 min of intracarotid infusion of 10-5 M bradykinin. An increased ionic conductance in frog pial venules was found during intra-or extravascular application of bradykinin (Olesen and Crone, 1986) . These results demon strate that very similar concentrations of brady kinin reaching the kininergic receptors from both the intra-and extravascular side can open the BBB. Employing various kininergic receptor agonists and antagonists, the receptors causing BBB opening in the cat could be characterized as B 2 -kininergic re ceptors (U nterberg et aI. , 1984) .
The bradykinin-induced extravasation of Na + fluorescein is primarily due to an increased perme ability of the vessel wall because intra-and extra vascular bradykinin caused a comparable leakage without and with concomitant vasomotor re sponses, respectively (Unterberg et aI. , 1984) . Ar terial vasodilatation per se that increases the intra extravascular driving force and the vascular surface area is not sufficient to induce penetration of tracers. However, there is no doubt that arterial di latation augments leakage if vascular permeability is increased at all (Wahl et aI. , 1985a) .
In situ, bradykinin has been found to be a potent dilator of feline pial arteries during perivascular mi croapplication (Wahl, 1982; Wahl et al. , 1983b Wahl et al. , , 1983c Whalley and Wahl, 1983a) . Accordingly, re laxing effects of bradykinin were recorded in iso lated extraparenchymal (Hamel et aI. , 1985; Har debo et aI. , 1985; Katusic et aI. , 1986; To da, 1977; Verrecchia et aI. , 1986; Wahl et aI., 1983b Wahl et aI., , 1983c Whalley and Wahl, 1983a, 1983b; Whalley et aI. , 1983a Whalley et aI. , , 1983b Whalley, 1987; Whalley et aI. , 1987) and intraparenchymal cerebral arteries (Dacey et aI. , 1988) of various species, including humans. In situ, the response of pial arteries was slightly weaker during cortical superfusion in cats (Kontos et aI. , 1984; Unterberg et aI. , 1983b Unterberg et aI. , , 1984 Wahl et aI. , 1985a) and rabbits (Kamitani et aI. , 1985a (Kamitani et aI. , , 1985b . A reduced dilating action of bradykinin has been found under pathological conditions such as cortical spreading depression (Wahl et aI. , 1987b) . Furthermore, Kamitani et ai. (1985a) reported that endogenous bradykinin can be released from brain kininogen by cortical superfusion with kallikrein. According to the arterial dilatation an increase of CBF was measured during ventriculocisternal per fusion with bradykinin (Unterberg et aI. , 1983a) .
The diameter of feline pial veins was reduced in a dose-dependent fashion at concentrations higher than 4 x 10-7 M bradykinin during 30 min of cor tical superfusion (Unterberg et aI. , 1983b (Unterberg et aI. , , 1984 . This might be due to an active constriction of pial veins as found by Hardebo et ai. (1987) in isolated human pial veins above 10-6 M bradykinin. In con trast to the findings obtained during extravascular application, intracarotid infusion of bradykinin in cats revealing concentrations of 10-6_10-5 M in the sagittal sinus blood did not induce a change in diameter of pial arteries and pial veins (U nterberg et aI. , 1984) , or in CBF and metabolism during steady-state conditions (U nterberg et aI. , 1985a ). These findings demonstrate that only extravascular bradykinin does reach the kininergic receptors in volved. The arterial dilatation is mediated by Bz kininergic receptors as demonstrated in situ and in vitro (Ellis et aI. , 1987 c; Whalley, 1987; Whalley and Wahl, 1983a; Whalley et ai. , 1983a Whalley et ai. , , 1987 .
Studies using isolated cerebral arteries of various species have shown that the dilating response to bradykinin is endothelium dependent (Hardebo et aI. , 1985; Katusic et aI. , 1986; Verrecchia et aI. , 1986; Whalley et aI. , 1984 Whalley et aI. , , 1987 . These in situ and in vitro findings would be compatible with a pro cess mediated (a) by smooth muscle B2-kininergic receptors transmitting a signal to the endothelium, which then initiates the relaxation of smooth muscle cells by release of an endothelium-derived relaxing factor or other compounds, or (b) by endo thelial B2-kininergic receptors localized at the anti luminal side. If both B2-kininergic receptors re sponsible for dilatation and permeability increase are localized at the endothelium, one has to assume either two B2-receptor subpopulations or two dif ferent secondary mechanisms. The increase of vas cular permeability and diameter induced by brady kinin can explain the formation of brain edema found in dogs after 3 h of ventriculocisternal perfusion with artificial CSF containing 2 . 5 x 10-6 M bradykinin. This led to a significant rise of tissue water content in gray and white matter in dogs and a decrease of electrical tissue impedance in cats (Unterberg et aI. , 1985a) .
Bradykinin can be formed in the blood or in the brain itself, which contains all components of an in traparenchymal kallikrein kinin system, as re viewed elsewhere (Wahl et aI. , 1986a (Wahl et aI. , , 1987a . Fur thermore, Maier-Hauff et aI. (1984a) found uptake of plasma kininogens in cats subjected to a cortical cold lesion. Within 7 h after the trauma up to 600 ng bradykinin/g fresh tissue were released in focal ne crotic areas and 200 ng/g fresh tissue in perifocal edematous tissue. Formation of kinins was in creased by additional ischemia due to an increase of intracranial pressure. Under these conditions, bradykinin concentrations of 10-7 to 10-6 M can be estimated in the interstitial fluid. This clearly dem onstrates that under traumatic conditions endoge nous bradykinin can be generated in concentrations sufficient to induce vasomotor and permeability ef fects as described above.
Further evidence for a mediator role of brady kinin in brain edema is provided by therapeutic re sults. The cold-induced brain swelling could signifi cantly be reduced by treatment with the kaUikrein inhibitor aprotinin (Unterberg et aI. , 1986) . Correspondingly, the cerebral arteriolar dilatation of rats after concussive brain injury accompanied by a seven to eightfold increase of brain bradykinin (Ellis et aI. , 1987a) could be reduced by pretreat ment with a B2-kininergic receptor antagonist (Ellis et aI. , 1987b) .
Ta ken together, all results concerning perme ability increase, vasomotor response, tissue con centration, edema formation, and therapeutic ben efits favor bradykinin as a mediator of brain edema.
SEROTONIN (5-HT)
Approximately 10 years ago Westergaard (1975a Westergaard ( , 1975b Westergaard ( , 1977 demonstrated in mice, after ventric ular application of 50-800 ,... ., g 5-hydroxytryptamine (5-HT), an opening of the BBB for intravenously given horseradish peroxidase that was ascribed to an enhanced vesicular transport in arterioles, capil laries, and venules. However, leakage of Evans blue could not be detected in the rat after an intra venous bolus of �6 x 10-8 to 6 X 10 -7 M 5-HT/kg BW (Gabbiani et aI. , 1970; Saria et aI. , 1983) . Simi larly, neither intracisternal nor intravenous admin istration of 5-HT caused an extravasation of 14 C-in ulin or Evans-blue-albumin in the rat (Hardebo et aI. , 1981) , which confirmed earlier studies in monkeys with ventriculocisternal perfusion of 5-HT (Solomon, 1974) . In contrast, intravascular but not extravascular administration of 5-HT 00-6-10-4 M) decreased the electrical resistance in frog pial venules (Olesen, 1985) . Because this ef fect could be blocked by ketanserin or verapamil, a 5-HT2 receptor mediated influx of Ca 2 + followed by endothelial contraction and opening of tight junctions was suggested. By this mechanism 5-HT can induce a penetration of small ions but not of larger compounds because N a + -fluorescein did not leak into the frog brain after 5-HT administration (Olesen, 1985) . This may also indicate that the ef fect of 5-HT on BBB permeability is species depen dent.
Whether the vasomotor effects of 5-HT facilitate the extravasation after opening of the BBB depends on the amount of its release. In situ, small amounts of extravascularly applied 5-HT and synthetic an alogs dilate small feline pial arteries (Auer et aI. , 1985; Edvinsson et aI. , 1977a; Grome and Harper, 1983a; Harper and MacKenzie, 1977b) by receptors that can be blocked by propranolol (Edvinsson et aI. , 1977a ). This effect is just the opposite of the in vitro prevailing constrictor action of 5-HT (Ed vinsson et aI. , 1978; Forster and Whalley, 1982; Hardebo et aI., 1978; Miiller-Schweinitzer, 1986; To da and Fujita, 1973; Young et aI. , 1986) .
Intravascular 5-HT does not change CBF (Harper and MacKenzie, 1977a) . However, appli cation of synthetic diffusible 5-HT agonists, admin istration of 5-HT with simultaneous inhibition of its degradation or after osmotic opening of the BBB induces a decrease of cerebral consumption of O2 and glucose, which is accompanied by a decrease of CBF (Grome and Harper, 1983b Harper and MacKenzie, 1977a) . Under these cir cumstances, which may simulate the situation after brain injury, a drop in blood pressure in the micro circulation can be assumed, which would coun teract edema formation.
In addition to circulating platelets, 5-HT can be released from mast cells, which are present in lep tomeninges and brain (see section on histamine below), from vascular endothelium (Spatz et aI. , 1986) , or from serotoninergic vascular nerves origi nating in the raphe nuclei (Di Carlo, 1984; Ed vinsson et al. , 1983a Ed vinsson et al. , , 1984 Griffith et aI. , 1982; Scatton et aI. , 1983 Scatton et aI. , , 1985 Young et aI. , 1986) . In addition, cerebral neurons are innervated by sero toninergic afferents (Beaudet and Descarries, 1976; Lidov et aI. , 1980 ). An increased concentration of 5-hydroxyindoleacetic acid in ventricular CSF was detected in patients in the first few days after se-
vere head injury (Porta et aI. , 1975) . Furthermore, a stimulation of 5-HT turnover has been found in rat brain after cold lesion (Pappius and Dadoun, 1987; Pappius and Wolfe, 1983a, 1983b) . However, these authors did not see a causal relationship between 5-HT release and edema formation but suggested that the reduced glucose consumption in the trau matized hemisphere was due to 5-HT and was inde pendent of edema formation (Pappius, 1986) . Simi larly, Fenske et al. (1976) found that the cold lesion-induced edema was not increased after addi tional ventriculocisternal perfusion with 5-HT. In rat models, Dey (1986a, 1986b) could elicit opening of the BBB for Evans blue by heat stress or by 8-h immobilization stress. Because plasma and brain concentrations of 5-HT were four to sixfold enhanced, the authors suggested an in volvement of 5-HT. Pretreatment with the 5-HT synthesis inhibitor p-chlorophenyl-alanine, or the 5-HT antagonist cyproheptadine prevented the BBB opening during heat stress.
Thus, 5-HT is able to increase the permeability of the BBB. However, it is unlikely that 5-HT is in volved in edema formation after brain injury.
HISTAMINE
Intravascular administration of histamine has fre quently been reported to elicit extravasation of various tracers (MW, 103 -67 ,000) into brain tissue (Domer et aI. , 1983; Dux and Joo, 1982; Foldes and Kelentei, 1954; Gross et aI. , 1981c Gross et aI. , , 1982 Hurst and Davies, 1950) . However, no change of BBB perme ability due to histamine has also been found in the guinea pig, cat, dog, rat, and frog (Broman and Lindberg-Broman, 1945; Gabbiani et aI. , 1970; Kilzer et aI. , 1985; Martins et aI. , 1980; Olesen and Crone, 1986; Saria et aI. , 1983; Wolff et aI. , 1975) . Te chnical or methodical reasons and species differ ences, especially concerning the experiments con ducted in frogs (Olesen and Crone, 1986) , may ac count for these negative results obtained with intra and extravascular application.
Recently, the effect of histamine applied by cor tical superfusion on BBB permeability was studied by intravital fluorescence microscopy in cats (Schilling et aI. , 1987a (Schilling et aI. , , 1987b (Schilling et aI. , , 1987c . Leakage of Na+-fluorescein (Stokes' radius, 5. 5 A) started at a concentration of 10-9 M histamine whereas extrav asation of FITC-dextran 62,000 (Stokes' radius, 60 A) and 150,000 (Stokes' radius, 87 A) was first ob served at 10-8 M and 10-6 M, respectively. Extra vasation of FITC-albumin was found by Olesen (1987c) after cortical superfusion with 10-4 M his tamine in rats. To gether with the positive results obtained with intravascular application of hista mine, the latter results indicate that histamine in duces an un selective increase in BBB permeability by opening functional pores with a diameter of at least 180 A.
The endothelial receptor mediating the increase in permeability obviously can be reached from both the extra-and intravascular side. Employing spe cific agonists and antagonists, a Hz receptor could be characterized (Dux and Joo, 1982; Gross et ai. , 1982; Schilling et ai. , unpublished observations) . There is some evidence that this increase might be due to augmented pinocytotic activity (Dux and Joo, 1982; Gross et ai. , 1982) , which could well ex plain the unspecific opening of the BBB. Vesicular transfer activity appears to be linked to Hz re ceptors mediating adenylate cyclase activation (Joo, 1972; Joo et ai. , 1975; Karnushina et ai. , 1980) . An alternative explanation for the effect of hista mine on BBB permeability would be an opening of tight junctions.
Although not yet proven for cere bral vessels, several findings in peripheral vessels support the formation of paracellular pathways by histamine (Fox et ai. , 1980; Grega, 1986; Majno and Palade, 1961) .
During cortical superfusion tracer extravasation started at 10-9 M histamine, whereas a pronounced increase in pial arterial and venular diameter was only found at higher concentrations (Schilling et ai. , 1987 (Schilling et ai. , a, 1987 (Schilling et ai. , b, 1987 . This indicates that the leakage of tracers induced by histamine is primarily due to an increased permeability but may be en hanced by vasodilatation as discussed earlier in the section on bradykinin.
The vasomotor effects of histamine are best studied in cats. By means of perivascular microap plication (Edvinsson et ai. , 1983b; Gross et ai. , 1981b; Wahl and Kuschinsky, 1979) or cortical su perfusion (Martins et ai. , 1980; Schilling et ai. , 1987a Schilling et ai. , , 1987b Schilling et ai. , , 1987c histamine dilates pial arteries. U sing various agonists and antagonists this dilata tion was shown to be mainly mediated by Hz re ceptors, but HI receptors are also present (Ed vinsson et ai. , 1983b; Gross, 1981; Gross et ai. , 1981b; Martins et ai. , 1980; Wahl and Kuschinsky, 1979) . Intraparenchymal vessels also dilate to intra ventricular histamine (De Ley et ai. , 1982) . In addi tion to its direct vasomotor effects histamine may also inhibit norepinephrine release from perivas cular sympathetic nerves (Gross, 1982) . Intraca rotid infusion of histamine increases CBF without affecting glucose metabolism in rats, however, only after osmotic opening of the BBB (Gross et ai. , 1981a) . This indicates that these H2 receptors can be reached only from the extravascular side. In ac cordance with the in vivo findings are results ob tained in isolated precontracted cerebral arteries from cats, rats, and humans. The dose-dependent relaxation of the intra-and extraparenchymal ar teries induced by histamine was mainly mediated by Hz receptors (Dacey and Bassett, 1987; Ed vinsson and Owman, 1975; Edvinsson et ai. , 1976 Edvinsson et ai. , , 1983b and independent of the endothelium (Har debo et ai. , 1985) . Therefore, this receptor has to be localized on smooth-muscle cells.
In contrast, a marked constriction of pial arteries due to histamine was found in rabbits under in situ (Kamitani et ai. , 1985b) and in vitro conditions. In this species, HI receptors located on smooth muscle cells are functionally dominant (Kim et ai. , 1986; Sercombe et ai. , 1986) .
In pial veins, no vasomotor effect of perivascu larly applied histamine (Gross et ai. , 1981b) was found in cats. However, venous diameters in creased during cortical superfusion of histamine (Martins et ai. , 1980; Schilling et ai. , 1987a Schilling et ai. , , 1987b Schilling et ai. , , 1987c probably due to a pressure-dependent reac tion.
The marked permeability enhancing effect of his tamine on cerebral vessels together with its dilatory potency suggest a possible mediator role of hista mine in cerebral edema. Indeed, it has been shown by Gross et ai. (1982) that histamine can increase brain water content and lead to swelling of astro cytic perivascular end-feet, confirming similar light microscopic observations of Foldes and Kelentei (1954) .
From these results a pathophysiological role of histamine in formation of brain edema under dif ferent pathological conditions (e. g. , inflammatory diseases of the meninges or the brain parenchyma) might be suggested. Histamine may be released from the vessel wall itself (El-Ackad and Brody, 1975) , or from perivascular nerves (Steinbusch and Verhofstad, 1986) . Additional, probably more im portant sources of histamine in the brain are mast cells, usually located in close association with blood vessels (Dropp, 1976; Edvinsson et ai. , 1976 Edvinsson et ai. , , 1977b Goldschmidt et ai. , 1985; Ibrahim, 1974; Kiernan, 1976; Steinbusch and Mulder, 1984) and histaminergic neurones projecting diffusely to nearly all parts of the brain (Garbarg et ai. , 1976; Pollard and Schwartz, 1987; Watanabe et ai. , 1985; Wouterlood et aI. , 1986) .
Only a few studies provide indirect evidence for a pathophysiological role of histamine in brain edema. Dux et ai. (1987) found that cerebral edema induced by experimental pneumothorax in newborn piglets could be significantly diminished by applica-tion of H 1 -and Hrreceptor antagonists. A role of histamine in the development of postirradiation brain edema was described by Csanda (1980) and Joo et ai. (1976) because Evans blue extravasation was significantly reduced by a H2-receptor antago nist in dogs and cats. Thus, histamine increases permeability and may enhance extravasation by va sodilatation, both resulting in brain edema. How ever, further therapeutic studies are needed to con firm the mediator function of histamine in brain edema.
ARACHIDONIC ACID
A variety of studies in the brain showed BBB damage by local administration or tissue injection of arachidonic acid (Aritake et aI. , 1983; Black and Hoff, 1985; Chan and Fishman, 1984; Chan et aI. , 1983; Kontos et aI. , 1980; Unterberg et aI. , 1985b Unterberg et aI. , , 1987a Unterberg et aI. , , 1987b Unterberg et aI. , , 1988b Wakai et aI. , 1982; Wei et aI. , 1986) . Mostly, uptake of intravenously adminis tered BBB indicators into brain tissue was shown in these studies. Recently, investigations on BBB function and vasomotor response were performed in cats with cortical superfusion of arachidonic acid using N a + -fluorescein or FITC-dextran (MW 62,000) as BBB indicators (Unterberg et aI. , 1985b (Unterberg et aI. , , 1987a Wahl et aI. , 1985a Wahl et aI. , , 1985b . Arachidonic acid caused an unspecific opening of the BBB not only for Na+-fluorescein but also for FITC-dextran, which started in some experiments at concentra tions of 3 x 10-5 M arachidonic acid. At 3 x 10-3 M arachidonic acid leakage of both tracers was always found. Further experiments on pharmacological inhibition of the dif ferent pathways (cyclooxygenase or lipoxygenase) suggest that arachidonic acid itself but not its deg radation products were responsible for the induc tion of barrier opening. Pretreatment with indo methacin or BW 755 C, an inhibitor of cyclooxy genase and lipoxygenase, did not prevent barrier opening by arachidonic acid for Na + -fluorescein. This conclusion is partly in conflict with earlier ob servations of Kontos et ai. (1980) and Black and Hoff (1985) . Kontos et al. (1980) found that the ara chidonate-induced and histologically determined lesions in cerebral arterioles could be prevented by systemic administration of indomethacin and Black and Hoff (1985) reported that BW 755 C attenuated the uptake of Evans blue after intracerebral injec tion of arachidonic acid. The mechanism by which arachidonic acid elicits barrier damage is not fully understood at the moment. Two explanations might be taken into consideration. Incorporation of ara chidonic acid and penetration into cell membranes J Cereb Blood Flow Metab. Vol. 8, No.5, 1988 due to the ampholytic nature of arachidonic acid might considerably alter the physicochemical prop erties of the membranes and membrane function (Katz and Messineo, 1981) . The other explanation regards arachidonic acid as a chemoattractant. Studies by Lundberg et ai. (1983) and Smedegard (1985) with hamster cheek pouch preparations indi cate that vascular leakage secondary to arachidonic acid results from an interaction between leukocytes and vascular endothelium. This finding perfectly agrees with current electron microscopical obser vations on pial vessels revealing marked alterations of the venous endothelium, and attachment and penetration of polymorphonuclear leukocytes through the cerebral endothelial barrier after cor tical superfusion with arachidonic acid (Unterberg et aI. , 1987a) . This might indicate that opening of the barrier by arachidonic acid is mediated by leu kocytes or their products and leads to damage of endothelial membranes.
In the studies of Unterberg et al. (1987a) the va somotor response of the pial arteries to arachidonic acid was moderate. Thus, a weak constriction (5-10%) appeared to prevail in concentrations of arachidonic acid from 3 x 10-6 to 3 X 10-4 M, whereas 3 x 10-3 M elicited no significant re sponse. It has to be mentioned, however, that Bu sija and Heistad (1983), Kontos et al. (1980) , and Wei et al. (1980) reported dose-dependent dilata tions of arteries by arachidonic acid that were ex plained by conversion to free radicals (Kontos et aI. , 1980) . Interestingly, arachidonate did not cause a vasomotor response in cerebral veins, although the venular endothelium was markedly altered (U n terberg et aI. , 1987a). When considered together, the rather weak vasomotor effects of arachidonic acid itself are not likely to enhance vasogenic edema.
Nevertheless, there is no question that arachi donic acid is capable of inducing brain edema, both cytotoxic and vasogenic edema (Chan et aI. , 1983; Chan and Fishman, 1984) . Unterberg et al. (1987b Unterberg et al. ( , 1988b reported that an infusion-induced brain edema was markedly enhanced (by 35%) by addi tion of arachidonic acid to the infusion medium. Release of arachidonic acid from brain tissue has been observed after various cerebral insults, such as severe hypoxia, cerebral ischemia, seizures, and severe head injury (Bazan, 1971; Bazan and Rodri guez de Turco, 1980; Bhakoo et aI. , 1984; Gardiner et al. , 1981; Maier-Hauff et aI. , 1984b; Siesjo, 1981) . Maier-Hauff et al. (1984b) found 2 x 10-4 M arachidonate in vasogenic edema fluid after a freezing lesion of the cortex. Furthermore, data from Yoshida et al. (1982 Yoshida et al. ( , 1983 and Bhakoo et ai.
(1984) can be used to predict concentrations of 10-5 to 10-4 M arachidonic acid after ischemia. These concentrations are certainly in a range in which ar achidonate definitely induces vessel damage, sup porting the assumption that arachidonic acid acts as mediator of BBB damage and vasogenic edema after cerebral insults.
Whether or not arachidonic acid itself represents the noxious agent, inhibition of arachidonic acid re lease after cerebral insults would be a worthwhile approach for a rational therapy of secondary brain damage. Steroids are known to attenuate arachi donic acid release by inhibition of phospholipase Az. Although the effectiveness of steroid therapy in regard to inhibition of arachidonic acid release in the brain is under dispute (Pappius and Wolfe, 1983b; Politi et aI., 1985) , the beneficial effect of steroids on vasogenic edema formation might be explained by inhibition of phospholipase and re duction of arachidonic acid release. There are nu merous studies on the effects of steroids on forma tion of vasogenic brain edema. Sugiura et al. (1980) , reviewing the experimental literature, came to the conclusion that the earlier steroid therapy com mences the more effective it is. However, start of treatment hours after acute insults is not signifi cantly beneficial.
LEUKOTRIENES
Leukotrienes are powerful metabolites of arachi donic acid generated via the lipoxygenase pathway. They are regarded as important mediators of in flammation because of their properties concerning smooth-muscle contractility and permeability in pe ripheral vessels, as well as leukocyte function (Samuelsson et aI. , 1980) . They have also been pro posed to act as mediators of brain edema (Black and Hoff, 1985) .
Reports on BBB dysfunction due to leukotrienes are controversial. Black (1984) reported that injec tion of leukotrienes into the brain of rats increased BBB permeability as evidenced by uptake of intra venously administered Evans blue. Mayhan et al. (1986a) noticed only minimal disruption of the bar rier of pial vessels to N a + -fluorescein after super fusing the cerebral cortex of hamsters with leuko triene C 4 . Using a very similar experimental ap proach, vasomotor and permeability effects of leukotrienes on pial vessels were also investigated in cats (Unterberg et aI. , 1987c (Unterberg et aI. , , 1988b (Unterberg et aI. , , 1988c Wahl et aI. , 1986b) . In these experiments leukotriene C 4 , D 4 , and E 4 were tested up to 2 f.LM. However, cor tical superfusion with leukotrienes did not induce any extravasation, even using the low-molecularweight BBB indicator Na+-fluorescein. Moreover, the authors were unable to detect extravasation of Evans blue after intraparenchymal injection of leu kotrienes into feline brains (Unterberg et aI. , 1987b (Unterberg et aI. , , 1988b Unterberg and Marmarou, unpublished data) . In this series, artificial CSF was slowly in fused into the frontal white matter of the right hemisphere to simulate formation and spread of va sogenic edema. CSF infused into the left hemi sphere contained leukotriene B 4 or leukotriene C 4 (�15 f.LM). After 150 min of infusion the brains were taken out and the water content of gray and white matter was determined microgravimetrically in serial coronal brain slices. Infusion of CSF re sulted in an increase of tissue water content, which was most pronounced in the slices adjacent to the needle track (infusion-induced edema). Addition of leukotrienes to CSF did not, however, augment water content in the experimental left hemisphere as compared with the hemisphere with infusion of CSF only (Unterberg et aI. , 1987b (Unterberg et aI. , , 1987c (Unterberg et aI. , , 1988b . Thus, it was concluded that leukotrienes do not promote edema or act as mediators of cerebral edema. Olesen and Crone (1986) reported that leu kotriene C 4 causes an increase of ionic conductance of frog pial venules. However, Hua et ai. (1985) found no increased cerebral permeability after i. v. infusion of leukotrienes in guinea pigs.
Although leukotrienes did not affect BBB perme ability in the cat (Unterberg et aI. , 1987c (Unterberg et aI. , , 1988c Wahl et aI. , 1986b) , their vasomotor effects during cortical superfusion were pronounced. All leuko trienes tested induced a marked and significant constriction of pial vessels of � 15-25%. Remark ably, constriction of veins was as pronounced as of arteries. There are only few other reports on vaso motor effects of leukotrienes on cerebral vessels in vivo. Kamitani et ai. (1985b) , Rosenblum (1985) , and Busija et al. (1986) also found constriction of pial arteries in rabbits, mice, and piglets ranging from 5-23%. Moreover, leukotrienes were found to constrict isolated human cerebral arteries (Tagari et aI. , 1983) . So far it is not clear whether there are specific receptors for leukotrienes in cerebral vessels.
Leukotriene concentrations are increased after cerebral ischemia, subarachnoid hemorrhage, con cussive brain injury (Moskowitz et aI. , 1984) and in tumors of the brain (Black et al. , 1986; Kiwak et aI. , 1985) . Kiwak et ai. (1985) state that the major source of leukotrienes under pathological condi tions is a nonvascular compartment within gray matter. Estimations of leukotriene concentrations under pathological conditions are in the range of 10-8-10-9 M. Therefore, the concentrations tested in the permeability studies are certainly above those seen in pathological states.
The conclusion that leukotrienes do not act as mediators of BBB damage and vasogenic edema is supported by the finding that inhibition of leuko triene synthesis by BW 755 C does not attenuate edema formation after a cortical freezing injury (U nterberg et a!. , 1987 c, 1988c ).
FREE RADICALS
Kontos et a!. (1980) proposed that the damaging properties of arachidonic acid on cerebral arteries are due to free radicals that are released during conversion of arachidonic acid to prostaglandins. Wei et a!. (1985) reported that superfusion of the cerebral cortex with oxygen free radicals caused endothelial lesions and arterial dilatation. More over, demonstrated that superfu sion of the cortical surface with arachidonic acid caused extravasation of horseradish peroxidase and albumin in cats. Because this leakage could be pre vented by simultaneous application of free radical scavengers, superoxide dismutase and catalase, the authors concluded an involvement of oxygen free radicals. Findings of Olesen (1987b) support the permeability-enhancing properties of free radicals on cerebral vessels. Free radicals induced a de crease of the electrical resistance of pial venules in frogs, indicating an increase of ionic permeability that could be prevented by superoxide dismutase and catalase. Also, injection of a free radical gener ating system into the brain was found to cause up take of intravenously administered Evans blue (Chan et a!. , 1984 (Chan et a!. , , 1987 . In contrast to these ob servations, cortical superfusion with a free radical generating system consisting of xanthine oxydase and hypoxanthine in cats caused only moderate ex travasation of N a + -fluorescein, whereas leakage of FITC-dextran was never observed (Unterberg et a!. , 1988a; Wahl et aI. , 1986b) . Extravasation was enhanced by an additional hypertonicity of the su perfusion medium, which led also to leakage of FITC-dextran (MW 62, 000) in some cases (Unter berg et a!. , 1988a; Wahl et aI. , 1986b) . A direct tox icity on endothelial cells most likely represents the mechanism by which free radicals cause BBB damage (Kontos, 1985) .
The findings concerning vasomotor effects of free radicals on cerebral vessels are divergent. Dila tory effects have been reported by Rosenblum (1983) and by Wei et a!. (1985) . Dilatation was most pronounced in small arterioles. In contrast to these findings Unterberg et al. (1988a) and Wahl et al. (l986b) found a moderate dilatation when super-J Cereb Blood Flow Metah, Vol. 8, No.5, 1988 fusing the feline cortex with hypoxanthine and xanthine-oxydase under normotonic conditions. There is evidence that dilating effects of free rad icals reported earlier might be caused by hyper tonic superfusion media (U nterberg et aI. , 1988a; Wahl et aI. , 1985a) . The mechanism by which free radicals dilate cerebral vessels is unknown.
Oxygen-derived free radicals (FR) are generated during hypertensive insults, after cerebral isch emia, and after trauma (Demopoulos et aI. , 1979; Kontos, 1985; Kontos and Wei, 1986; Siesjo, 1981; Siesjo et aI. , 1985; Suzuki and Yagi, 1974) . Super oxide radicals can be assayed by the reduction of nitroblue tetrazolium to nitroblue formazan. Re cently, a sixfold increase of brain level of nitroblue formazan was found at 1 h after cold injury in rats (Chan et aI. , 1987) .
The therapeutic principle of inactivating free rad icals with substances, such as mannitol, dimethyl sulfoxide, tocopherol, catalase, and superoxide dis mutase has been tested under many experimental conditions. Kontos et al. (1980) and Wei et al. (1981) reported that mannitol markedly reduced the noxious effects of free radicals on cerebral arte rioles. Chan et a!. (1987) demonstrated that cold-in duced vasogenic edema in rats was attenuated by treatment with liposome-entrapped superoxide dis mutase. Other reports on treatment of edema for mation with superoxide dismutase are controversial (Long, 1988) . Therefore, further studies are needed to clarify the potential of free radical scavenging as a useful modality to treat edema formation.
Altogether, the evidence that free radicals play a major role in edema generation or BBB breakdown is far from being complete. On the other hand, these substances might contribute among others to cause cerebrovascular damage.
CONCLUSIONS
The possible role of several autacoids as medi ators of BBB opening and development of vaso genic brain edema (in animal models) is inferred by considering (a) their effects on cerebrovascular per meability, (b) their vasomotor responses, which might increase driving forces for transmural bulk flow, (c) their influence on edema formation, (d) their actual concentration in interstitial fluid or ce rebral tissue during pathological events, and (e) the therapeutic results after specific treatment as sum marized in Ta ble 1.
Bradykinin is capable of inducing brain edema, and its tissue concentration is increased after ex perimental brain injury. Edema formation is. pri marily caused by an increase of BBB permeability 1\' strong increase; t increase; ( t ) moderate increase; t decrease; n.d. not determined; ? questionable; -no change or no effect; + +, + positive effect. Mediators of vasogenic edema should (a) increase cerebrovascular permeability and cause extravasation that might be enhanced by (b) arterial dilatation. Furthermore, evidence for chemical mediators should include that its cerebral application causes (c) vasogenic edema, that it is (d) released under pathological states, and that (e) formation of va so genic edema can be attenuated by specific inhibition of its release or its effect.
to small solutes and may be supported by an in crease of blood pressure in the microcirculation due to arterial dilatation and venous constriction. Because treatment with kallikrein inhibitors or B2-kininergic receptor antagonists exert beneficial ef fects, all criteria favor bradykinin as a mediator of BBB opening and edema formation.
Histamine opens the BBB unspecificaliy for small and large tracers. Extravasation and forma tion of brain edema may be increased by a strong arterial and venous dilatation. Because concentra tions of histamine in interstitial fluid or tissue have not been determined yet under pathological condi tions it has to be established whether effective his tamine concentrations are released in the brain. Furthermore, additional convincing therapeutic studies appear to be necessary.
Arachidonic acid leads to brain edema by an un specific opening of BBB for small and large tracers that appears to be mediated mainly by arachidonic acid itself. Arachidonic acid exerts only moderate vasomotor responses. Therefore, hydrostatic pres sure changes may only slightly contribute to edema generation. Because effective arachidonic acid con centrations have been detected in edema fluid after brain injury, arachidonic acid is a potent mediator of BBB opening and edema formation. However, further therapeutic studies with specific inhibition of arachidonic acid release are still necessary.
Leukotriene concentrations are increased after several pathological events. Leukotrienes are po tent constrictors of cerebral vessels. In most of the studies an opening of BBB due to leukotrienes and formation of edema was not detected. Therefore, leukotrienes cannot be considered mediators of edema. This conclusion is supported by a lack of therapeutic results with lipoxygenase inhibitors in experimental brain injury.
Free radicals that are released under various pathological conditions open BBB for tracers irreg ularly. Formation of edema may be facilitated by a slight arterial dilatation. Recent beneficial thera peutic results need further confirmation. 5-HT does not induce brain edema. In some studies opening of BBB due to 5-HT has been found that could not, however, be confirmed by others. Furthermore, after cold lesion, tissue con centrations of 5-HT or its metabolites appear not to be time-related to edema formation. Therefore, 5-HT may influence BBB function but appears not to be a mediator of edema generation.
Thus, bradykinin, arachidonic acid, histamine, and free radicals but not leukotrienes or 5-HT could be involved in the development of vasogenic brain edema. 
